SCHEMBL22940960

SCHEMBL22940960

COc1ncccc1-c1nc(C)cs1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.53
CYP2E1 P05181 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2A6 P11509 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2B6 P20813 1/20 0.47
GRM5 P41594 1/20 0.46
CYP19A1 P11511 2/20 0.44
BTK Q06187 1/20 0.43
ADRA1A P35348 1/20 0.43
GABRA1 P14867 3/20 0.43
GABRG2 P18507 3/20 0.43
GABRB3 P28472 3/20 0.43
GABRA3 P34903 3/20 0.43
GABRA2 P47869 3/20 0.43
GABRA5 P31644 2/20 0.43
EIF4E P06730 1/20 0.42
ELANE P08246 1/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22940965 0.77 PDE10A (0.56) PDE10ACYP2E1CYP3A4CYP2A6CYP2C9
Hydrochloric Acid SCHEMBL2658031 0.75 PDE10A (0.54) PDE10ACYP2E1CYP3A4CYP2A6CYP2C9
SCHEMBL29627426 0.73 PDE10A (0.51) PDE10ACYP2E1CYP3A4CYP2A6CYP2C9
SCHEMBL22939929 0.72 CCR1 (0.48) PDE10ACYP2A6GRM5BTKADRA1A
SCHEMBL17194924 0.72 ALDH1A1 (0.47) PDE10ACYP2E1CYP3A4CYP2A6CYP2C9
SCHEMBL15984791 0.72 BTK (0.44) PDE10ABTKELANENPC1RAB9A
SCHEMBL6844999 0.72 DYRK1A (0.51) PDE10ABTKNPC1RAB9AL3MBTL1
SCHEMBL29501236 0.72 BTK (0.50) PDE10ABTKNPC1RAB9AL3MBTL1
SCHEMBL2745266 0.71 QPCT (0.41) PDE10ACYP2E1CYP3A4CYP2A6CYP2C9
SCHEMBL9952500 0.71 BTK (0.43) PDE10ACYP19A1BTKELANENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584745-B2 Aromatic heterocyclic compound, intermediate thereof, preparation method therefor, and pharmaceutical composition and use thereof SHANGHAI YINGLI PHARMACEUTICAL CO., LTD (CN) 2023-02-21 US disclosed
US-20210032241-A1 AROMATIC HETEROCYCLIC COMPOUND, INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF SHANGHAI YINGLI PHARMACEUTICAL CO., LTD (CN) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210032241-A1 AROMATIC HETEROCYCLIC COMPOUND, INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF ALK, NOTUM, WEE1 PDE10A 645/4885CYP2E1 808/4885CYP3A4 102/4885
US-11584745-B2 Aromatic heterocyclic compound, intermediate thereof, preparation method therefor, and pharmaceutical composition and use thereof ALK, NOTUM, WEE1 PDE10A 645/4885CYP2E1 808/4885CYP3A4 102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.